MIA is a potential biomarker for tumour load in neurofibromatosis type 1.

  • Mateusz Kolanczyk
  • Viktor Felix Mautner
  • Nadine Kossler
  • Rosa Nguyen
  • Jirko Kühnisch
  • Tomasz Zemojtel
  • Aleksander Jamsheer
  • Eike Wegener
  • Boris Thurisch
  • Sigrid Tinschert
  • Nikola Holtkamp
  • Su-Jin Park
  • Patricia Birch
  • David Kendler
  • Anja Harder
  • Stefan Mundlos
  • Lan Kluwe

Abstract

Neurofibromatosis type 1 (NF1) is a frequent genetic disease characterized by multiple benign tumours with increased risk for malignancy. There is currently no biomarker for tumour load in NF1 patients.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1741-7015
DOIs
StatusVeröffentlicht - 2011
pubmed 21726432